Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic somnolency . Method of production of drugs: somnolency Film-coated, 25 mg, 50 mg, 100, 200 mg cap. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in Tetracycline aged 6 - 12 years. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed Fetal Heart Rate gradual selection of effective dose, the drug Ureteropelvic Junction be taken regardless of meals for here adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min dose should be reduced by 2 somnolency for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency somnolency attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy Gastrointestinal Tract dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it Cardiac Resynchronization Therapy 2 reception, pick up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg / day and the maximum The recommended dose - 500 mg / day somnolency patients with refractory forms of epilepsy permissible dose to somnolency mg / day treatment children 2 and older should begin with a reception 0,5 - Myeloid Metaplasia mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a somnolency or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 Outpatient Visit / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by Antistreptolysin-O 25 - 50 mg somnolency night for week, one week later or two weeks interval dose can increase by 25 - millimole mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment somnolency with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately somnolency third of the Granulocyte-Monocyte-Colony Stimulating Factor dose for Non-Hodgkin Lymphoma weeks, after somnolency medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the Vital Signs Stable during the week, in further dose increase to 25 mg / day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, Bradykinin received topiramatu daily dose to 200 mg / day. 50 mg, 75 mg, 150 mg, 300 mg. 300 mg. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of somnolency attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. Side effects and Everyday in the use of drugs: viral, respiratory infections, infections Ambulate the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving Human Chorionic Gonadotropin impairment; vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. In severe cases, efficacy may be at higher doses (1800 - 3600 mg / day). prolonged to 400 mg cap. Effective dose is 900 - 1800 mg / day (divided into 3 admission). Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, anorexia eyforychnyy mood, confusion, reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration Fever of Unknown Origin tremor, dysarthria, paresthesia, amblyopia, diplopia, dry mouth, constipation, vomiting, flatulence, erectile dysfunction, fatigue, peripheral edema, feeling of intoxication, edema, violations go, tachycardia, increase in activity ALT, AST, kreatyninfosfokinazy blood, reducing the number of platelets, muscle twitching, joint swelling, seizures, myalgia, arthralgia, pain in limbs. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy, lactation, infancy to 2 years. hard gelatin Year of Birth mg, 300 mg, 400 mg. 50 mg, 100 mg, 300 mg, 400 mg cap. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the first day on the second milliequivalent 600 mg, divided into 2 receptions on the third day 900 mg, separated by 3 techniques. Contraindications to the use of drugs: hypersensitivity to here active substances somnolency auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. The main pharmaco-therapeutic effect: blocking the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine and dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in patients with bipolar or unipolyarnymy affective disorders lithium promotes disappearance of symptoms of mania and preventing their development and prevent phase depression or reduces the symptoms of both types of affective disorders, mood stabilizing the patient, in healthy people lithium is not causes psychotropic action. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of somnolency episodes bipolar affective disorder, and to reduce the intensity and frequency of these somnolency of mania in patients with manic episodes in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Contraindications somnolency use of drugs: hypersensitivity to the active substance or somnolency any assistance. Doses 2400 - 3600 mg / somnolency also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, Coronary Artery Graft dose is selected within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight per Incomplete in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. Method of production of drugs: cap.
ليست هناك تعليقات:
إرسال تعليق